Hlavní strana Mezinárodní biotech události SMi Presents the 2nd Annual Conference

SMi Presents the 2nd Annual Conference

London (May 15-16, 2019)

The SMi Group is pleased to announce the second annual Injectable Drug Delivery conference which will be held in London on the 15th and 16th May 2019.

The global injectable drug delivery market is expected to grow from $400 billion to $1200 billion by 2046 with a CAGR of 12.8%.

The benefits of attending:

Developing on last year’s success, this event assembles an international audience to include regulatory, device design, packaging and formulation professionals. The devices need to be designed for the new generation of drugs and they need to provide safety with a strong patient focus. This event is will help inspire you to help drive this industry forward and learn about the predicted market trends, critical digital and chemical developments and the push for patient compliance in a changing regulatory landscape.

This conference offers a chance to learn about innovative injectable drug delivery systems with industrial insights on the following:

- Life cycle management for developing devices that are both user friendly and revenue effective

- Device design considerations

- Long acting injectables and bringing these therapeutics to market with case studies

- Connected devices, GDPR and cyber security programs

- Developments in primary packaging

- Growth in transdermal delivery and subcutaneous infusion devices

- Digital health partnerships

- Large volume patch pump innovation examples

Who should attend

Executives, Directors, VPs, Heads, Principals, Managers, Scientists, Researchers of:

• Autoinjectors

• Wearables

• Device Engineering

• Human Factors

• CMC

• Injectables

• Sterile Manufacturing

• Packaging

• Regulatory Affairs

Chair for 2019:

Featured Speakers:

Bjorg K. Hunter, Device Engineering Manager, GSK
Miranda Newbery, Human Factors Consultant, Inspired Usability
Blake Green, Regulatory Affairs Senior Manager, Devices, Amgen
Quentin Le Masne, Head of Engineering team - Electro-Medical / Drug Delivery Devices, Merck
Vasco Filipe, Formulation and Drug Process Development Section Head for Biologics, Sanofi
Stephen Paboojian, Senior Project Leader I for Device Development, Novartis
Tom Lawrie-Fussey, Digital Services Specialist, Cambridge Design Partnership
Terry Reed, Director of Business development, AstraZeneca
Joel Richard, Head of Technical and Pharmaceutical Operations, MedinCell